Revenue Clarity for Healthtech Founders
Your Clinical Champion Loves the Product. They Don't Sign the Contract.
For healthtech and digital health founders at $1M to $20M ARR whose growth has stalled or slowed.
The clinician who piloted your product is not the person who signs an enterprise contract. Procurement runs a compliance review your team was not ready for. The deal sits in legal for four months, then the champion changes jobs and the deal restarts from zero. Noir Dove runs a Deep Clarity Assessment before recommending anything, then builds the strategy your team runs for the next twelve months.
Four People Can Kill the Deal. Your Sales Process Was Built to Convince One of Them.
A health system doesn’t buy the way a single stakeholder buys. Four people have to say yes, in sequence, and each one can stall the deal alone. Most healthtech sales processes are built to win over the first one and hope the rest follow.
Win over the champion, and the other three still decide whether the deal closes.
Clinical Champion
Uses the product, can't sign for it
Excited about the workflow improvement. No budget authority, and no visibility into procurement timelines.
Procurement Lead
Controls the budget, has never seen a demo
Evaluates the contract on vendor risk and total cost. Rarely hears the clinical pitch that won the champion over.
Compliance & Security Officer
Surfaces HIPAA and SOC 2 questions in month 4
Enters the process late. A sales cycle built for month one has no answer ready when they finally do.
IT & Integration Lead
Owns the EHR integration timeline
A pilot that worked on a sandbox instance still has to clear a real integration queue, and that alone can stall go-live for two quarters.
Different Buyers, Same Buying Committee.
We’ve run the Clarity Assessment across the following healthtech and digital health segments.
Digital Therapeutics
Remote Patient Monitoring
Clinical Decision Support
Care Coordination Platforms
Health System Software & EHR-Adjacent Tools
Payer-Facing Technology
Provider Enablement & Workflow Tools
Digital Health Diagnostics
Behavioral & Mental Health Platforms
Revenue Cycle & Billing Technology
Patient Engagement Platforms
Clinical Trial & Research Technology
Healthtech Founders' Core Challenges
Founders Walk In With a Theory. Half the Time, It Is Wrong.
Every engagement surfaces a different root cause. These are the symptoms founders walk in with.
Sales promises compliance the product doesn't have yet
Reps close pilots by promising HIPAA or SOC 2 readiness the product hasn’t achieved. Deals stall in security review months later.
CROSS-FUNCTIONAL ALIGNMENT
Deals stuck in pilot purgatory
A department-level pilot runs for a year with no path to an enterprise contract, because nobody owns the expansion motion.
PIPELINE · REVENUE INTEGRITY
Positioning that doesn't survive procurement
The pitch lands with clinicians. It has no answer for the compliance officer’s first question.
POSITIONING · MESSAGING
Champion turnover kills deals silently
The clinical champion changes jobs mid-cycle and the deal restarts from zero, because the relationship was never institutionalized beyond one person.
CONVERSION SIGNAL ANALYSIS
Founder still the only clinical translator
Every deal above a certain size still needs the founder to answer a workflow question the sales team cannot.
COMMERCIAL SCALABILITY
Roadmap chasing the loudest health system
One demanding customer’s custom integration requests consume a quarter of engineering time meant for the product that would scale.
COMMERCIAL SCALABILITY
Clarity, Strategy, Alignment.
In That Sequence, Always.
In healthtech, executing the wrong strategy costs months, not a quarter. You leave with a playbook your team can run, not a findings document that sits in a folder.
Clarity
Both founders in the room. CRM review, pipeline analysis, team conversations, customer calls.
Strategy
A custom revenue playbook: positioning, ICP definition, pipeline architecture, sales motion.
Alignment
Team sessions across sales, marketing, and product so every function understands its role going forward.
Execution
Guided, trained, or managed through vetted partners. Only after diagnosis, strategy, and alignment are confirmed.
The sequence is not optional. Each step depends on the one before it.
The Pilot Renews Every Quarter.
The Enterprise Contract Never Comes.
A pilot that keeps renewing feels like progress. It is often the sign that nobody owns the expansion motion, and that the same generic fixes marketing agencies sell everywhere else will not touch it.
9–14 mo
Added to a sales cycle once compliance and security review starts late
3 champions
Average number of champion changes a stalled deal survives before it dies
$180K–$300K
Pipeline value tied up in pilots that never convert to an enterprise contract
A pilot renewed for the third time with no signed enterprise contract in sight. A compliance question in month four that a generic GTM consultant never saw coming. A champion who changed jobs and took the deal’s momentum with them. If two or more of these sound familiar, the fix isn’t more outbound, it’s a different diagnosis.
Why Noir Dove Understands Healthtech Better
You can hire a paid media specialist tomorrow. A firm that can sit across from a compliance officer and a clinical champion in the same week, and hold its own with both, is rare.
Sakshi is direct and structured. Founders who work with her leave knowing exactly what is broken, why it developed, and what has to change first. She makes the diagnosis actionable. Every recommendation comes with a sequence and a reason for the sequence.
Before Noir Dove, he spent six years inside a healthcare analytics startup, taking it from bootstrap to funded on zero-dollar marketing and co-authoring a US patent on health prediction systems. Creates the conditions where founders tell the truth about their business. Every recommendation stays grounded in what the team can carry forward.
Frequently Asked Questions (FAQs)
Are you a marketing agency?
No. We do not run campaigns, manage ad spend, or produce content on retainer. We diagnose why your commercial system is not producing predictable pipeline, then build the strategy your team runs. Execution, when needed, is scoped separately.
Do you help with HIPAA, SOC 2, or compliance positioning?
We are not a compliance consultancy and do not write your policies. The Clarity Assessment looks at when compliance and security questions surface in your sales cycle, and whether your positioning gives buyers what they need before procurement asks. Where the finding is a compliance gap, we tell you and point you to the right partner.
We already have a marketing and sales team. How would this work with them?
We do not replace your team or take over execution. The Clarity Assessment examines how marketing, sales, and product are currently working together. The Strategy phase gives your existing team a playbook to run. The Alignment workshop makes sure every function leaves with the same definition of who you sell to and why.
How long does the engagement take?
Clarity runs 4 to 6 weeks. Strategy runs 2 to 3 weeks after that. Alignment is a structured workshop once the playbook is built. Most founders have a completed playbook 8 to 10 weeks from kickoff.
Who actually runs the Clarity Assessment?
Both founders, Sakshi Dhiman and Jagsir Singh, are in every engagement. It is not delegated to a junior analyst. Every application is reviewed by them personally before an engagement starts.
The Champion Signed Off Months Ago. Procurement Still Hasn't. Find Out Why.
Talk to both founders directly. We start digging into which of the four buyers is actually stalling your deal, and what it will take to get every one of them to yes.